Skip to main content

Center for Valve & Structural Heart Disease

  • Valvular Heart Disease

    • Valvular heart disease is common, affecting over 10 million people in the U.S.
    • Symptoms may be heart failure, chest pain, or lightheadedness.
    • Once symptoms develop, survival becomes impaired and is worse than many advanced cancers
    • Life-saving therapy can now be performed with very small incisions, and very low risk.
    • Patients also may receive their valve therapy without general anesthesia, and be able to leave the hospital after a short stay (often less than three days).

    Center for Valve and Structural Heart Disease

    The Center for Valve and Structural Heart Disease at Minneapolis Heart Institute® at Abbott Northwestern Hospital is world renowned. We evaluate our patients in a dedicated clinic, using a multidisciplinary, heart-team approach. 

    Our team provides world-class care for a broad range of diseases affecting the cardiac valves and structural heart lesions. Patients benefit from expert evaluations that include advanced cardiac imaging with echocardiography, magnetic resonance imaging (MRI), and computed tomography (CT). A multidisciplinary approach enables the delivery of the most innovative transcatheter and surgical therapies for treating valve and structural heart disease, including investigational approaches that are provided at only a few centers in the world. 

    State-of-the-art therapies available:

    • Transcatheter mitral valve repair (MitraClip)
    • Transcatheter mitral valve replacement for native mitral regurgitation
    • Valve-in-valve therapy for prosthetic valve degeneration
    • Minimally-invasive mitral valve surgery (e.g., port access)
    • Mini-sternotomy aortic valve surgery
    • Paravalvular prosthetic leak repair
    • Transcatheter tricuspid valve repair
    • Balloon mitral valvuloplasty
    • Balloon aortic valvuloplasty
    • Alcohol septal ablation
    • Ventricular and aortic pseudoaneurysm transcatheter repair
    • Transcatheter closure of patent foramen ovale (PFO), atrial septal defect, and ventricular septal defect
    • Left atrial appendage closure

    Patient may be eligible for participation in clinical trials, and have access to unique and innovative therapies. Our center has a long history of participating in major clinical trials of valvular and structural heart disease and remains the global leader in this area.

    In April 2015, the first transcatheter mitral valve replacement in the U.S. was performed at our center. The procedure is performed through a small thoracotomy (i.e., incision between the ribs), and without the need for cardiopulmonary bypass (or heart-lung machine). Our center continues to have the highest volume of patients for this novel procedure in the world.

    Patient story

  • Make an appointment

    Call 612-863-8258 or email

    doctor uses a stethascope to listen to a patient's heart

    Find us

  • 800 E 28th St
    Minneapolis, MN 55407

    612-863-8258